Cite
HARVARD Citation
Hoberück, S. et al. (2019). Dual‐time‐point 64Cu‐PSMA‐617‐PET/CT in patients suffering from prostate cancer. Journal of labelled compounds & radiopharmaceuticals. pp. 523-532. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hoberück, S. et al. (2019). Dual‐time‐point 64Cu‐PSMA‐617‐PET/CT in patients suffering from prostate cancer. Journal of labelled compounds & radiopharmaceuticals. pp. 523-532. [Online].